1-10 of 10
Peter C Trask, PhD MPH
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Improvements in Health-Related Quality of Life and Symptoms in Patients with Previously Untreated Chronic Lymphocytic Leukemia: Final Results from the Phase II GIBB Study of the Combination of Obinutuzumab and Bendamustine

Alexey Danilov, MD PhD, Habte A Yimer, MD, Michael Boxer, MD, John M Burke, MD, Sunil Babu, MD, Jia Li, PhD, Yong Mun, PhD, Peter C Trask, PhD MPH, Anthony S Masaquel, PhD MPH, Jeff P. Sharman, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3491.
https://doi.org/10.1182/blood-2019-123630
Published: 2019
Journal Articles

Primary Results of the Health-Related Quality of Life Assessment from the Phase III Gadolin Study of Obinutuzumab Plus Bendamustine Compared with Bendamustine Alone in Patients with Rituximab-Refractory, Indolent Non-Hodgkin Lymphoma

Bruce D. Cheson, MD, Peter C Trask, PhD MPH, John Gribben, MDDSc, Natalie Dimier, Eva Kimby, MD PhD, Pieternella J Lugtenburg, MD PhD, Catherine Thieblemont, Elisabeth Wassner Fritsch, MD, Laurie H Sehn, MD MPH
Journal: Blood
Blood (2015) 126 (23): 1532.
https://doi.org/10.1182/blood.V126.23.1532.1532
Published: 2015
Journal Articles

Meta-Analytic Summary of the Burden of Pain and Fatigue in Multiple Myeloma

Peter C. Trask, PhD MPH, Mark Atkinson, PhD, Bhumi Trivedi, MBA, Andrew Palsgrove, BA, William Benton Jones, PhDMBA, Colleen McHorney, PhD
Journal: Blood
Blood (2014) 124 (21): 5967.
https://doi.org/10.1182/blood.V124.21.5967.5967
Published: 2014
Journal Articles

Symptoms of Multiple Myeloma: Results of Hybrid Concept Elicitation/Cognitive Debriefing Interviews

Peter C. Trask, PhD MPH, Bhumi Trivedi, MBA, Andrew Palsgrove, BA, William Benton Jones, PhDMBA, Colleen McHorney, PhD
Journal: Blood
Blood (2014) 124 (21): 5973.
https://doi.org/10.1182/blood.V124.21.5973.5973
Published: 2014
Journal Articles

Efficacy and Safety Of Treatments For Relapsed Or Refractory Mantle Cell Lymphoma (MCL): Results Of a Systematic Literature Review

Annete Njue, PhD, Peter C Trask, PhD, MPH, Ann Colosia, PhD, Robert Olivares, MD, MSc, Shahnaz Khan, MPH, Adeline Abbe, MSc, Rachel Lee Police, MPH, Jianmin Wang, PhD, MD, Elizabeth Sherrill, MS, James A. Kaye, MD, DrPH, Farrukh T Awan, MD
Journal: Blood
Blood (2013) 122 (21): 5099.
https://doi.org/10.1182/blood.V122.21.5099.5099
Published: 2013
Journal Articles

Efficacy and Safety Of Treatments For Relapsed Or Refractory DLBCL: Results Of a Systematic Literature Review

Ann Colosia, PhD, Peter C Trask, PhD, MPH, Robert Olivares, MD, MSc, Shahnaz Khan, MPH, Adeline Abbe, MSc, Rachel Lee Police, MPH, Annete Njue, PhD, Jianmin Wang, PhD, MD, Elizabeth Sherrill, MS, Rodrigo Ruiz-Soto, MD, MSc, James A. Kaye, MD, DrPH, Farrukh T Awan, MD
Journal: Blood
Blood (2013) 122 (21): 5104.
https://doi.org/10.1182/blood.V122.21.5104.5104
Published: 2013
Journal Articles

Treatments For Relapsed Or Refractory Follicular Lymphoma (RRFL): Results Of a Systematic Literature Review (SLR) and Meta-Analysis

Rachel Lee Police, MPH, Peter C Trask, PhD, MPH, Ann Colosia, PhD, Robert Olivares, MD, MSc, Shahnaz Khan, MPH, Adeline Abbe, MSc, Annete Njue, PhD, Jianmin Wang, PhD, MD, Sherrill Elizabeth, MS, James A. Kaye, MD, DrPH, Rodrigo Ruiz-Soto, MD, MSc, Mehdi Hamadani, MD
Journal: Blood
Blood (2013) 122 (21): 5106.
https://doi.org/10.1182/blood.V122.21.5106.5106
Published: 2013
Journal Articles

Qualitative Assessment Of Symptoms and Functional Impact In Relapsed/Refractory Multiple Myeloma Patients and Comparison To The EORTC QLQ-C30 and My-20, FACT-MM, and MDASI-MM

Peter C Trask, PhD, MPH, Fiona Taylor, MBiochem, Alan Shields, PhD, Meghan Gallagher, MSc, Jyotsna Mehta, MSc, Catherine Foley, MPH, Funke Olude, MPH, Roger Lamoureux, Ramon Iovin, PhD, Karl Hsu, MD
Journal: Blood
Blood (2013) 122 (21): 2989.
https://doi.org/10.1182/blood.V122.21.2989.2989
Published: 2013
Journal Articles

Treatment Response Patterns and Related Prognostic Indicators in Chronic Myeloid Leukemia (CML) Patients: A Multi-Country Medical Record Review Study

Peter C Trask, PhD, MPH, Debanjali Mitra, MA, MBA, Shrividya Iyer, PhD, Sean D Candrilli, PhD, James A. Kaye, MD, DrPH
Journal: Blood
Blood (2011) 118 (21): 3131.
https://doi.org/10.1182/blood.V118.21.3131.3131
Published: 2011
Journal Articles

Health Care Resource Utilization and Cost in Patients with Chronic Myeloid Leukemia in a Privately Insured Patient Population in the United States,

Shrividya Iyer, PhD, Peter C Trask, PhD, MPH, Gordon Siu, MS, Jack Mardekian, PhD
Journal: Blood
Blood (2011) 118 (21): 4220.
https://doi.org/10.1182/blood.V118.21.4220.4220
Published: 2011